Insider Trading activities of Laboratory Corp Of America Holdings insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Laboratory Corp Of America Holdings since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Laboratory Corp Of America Holdings since year 2005. Table 2 shows the detailed insider transactions of Laboratory Corp Of America Holdings since 2005. The reporting company's ticker symbol is LH. The reporting company's CIK number is 920148.
The total value of stock buying since 2005 is $477,729.
The total value of stock sales since 2005 is $529,918,149.
The total value of stock option exercises since 2005 is $244,248,429.


 1   2   3 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Laboratory Corp Of America Holdings (LH).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 971 $149,067 0 $0
2017-09 0 $0 177,400 $27,861,599 177,553 $16,097,275
2017-08 0 $0 48,439 $7,587,101 34,600 $2,400,409
2017-06 0 $0 0 $0 4,050 $0
2017-05 0 $0 4,605 $646,311 992 $76,959
2017-03 0 $0 2,300 $327,671 17,184 $0
2017-02 0 $0 7,292 $1,035,163 47,104 $629,066
2016-08 0 $0 10,169 $1,426,806 992 $76,959
2016-06 0 $0 196,400 $25,221,491 208,550 $13,777,460
2016-04 0 $0 13,132 $1,655,471 0 $0
2016-03 0 $0 24,203 $2,826,735 42,963 $0
2016-02 0 $0 5,721 $598,066 1,296 $76,943
2016-01 0 $0 1,215 $144,645 0 $0
2015-12 0 $0 1,010 $124,543 0 $0
2015-11 0 $0 1,850 $229,958 1,850 $119,177
2015-10 0 $0 0 $0 1,296 $76,943
2015-08 0 $0 50,000 $6,402,900 50,000 $4,018,500
2015-07 0 $0 50,000 $6,086,200 69,990 $4,018,500
2015-06 0 $0 50,000 $5,911,500 54,050 $4,018,500
2015-05 0 $0 2,261 $268,178 1,296 $76,943
2015-04 0 $0 2,936 $366,244 1,714 $76,992
2015-03 0 $0 21,862 $2,772,030 19,200 $1,685,760
2015-02 0 $0 45,740 $5,541,965 45,463 $0
2014-12 0 $0 0 $0 624 $0
2014-09 0 $0 67,234 $7,072,786 65,234 $4,933,647
2014-08 0 $0 65,233 $6,921,482 65,233 $4,933,571
2014-07 0 $0 65,233 $6,899,368 65,233 $4,933,571
2014-06 0 $0 98,567 $10,223,278 95,967 $8,034,818
2014-05 0 $0 1,984 $194,979 16,321 $1,495,766
2014-04 0 $0 8,397 $826,983 6,502 $271,898
2014-03 0 $0 27,951 $2,646,475 19,166 $1,626,426
2014-02 0 $0 5,327 $482,009 18,347 $0
2014-01 0 $0 24,200 $2,181,630 24,200 $1,452,968
2013-12 0 $0 25,000 $2,269,750 25,000 $1,501,000
2013-11 0 $0 35,400 $3,750,898 35,000 $2,086,700
2013-10 0 $0 49,400 $5,017,525 49,400 $3,404,200
2013-09 0 $0 25,000 $2,476,625 25,000 $1,501,000
2013-08 0 $0 32,429 $3,134,615 25,000 $1,501,000
2013-07 0 $0 25,000 $2,442,900 25,000 $1,501,000
2013-06 0 $0 88,100 $8,759,653 88,100 $5,927,465
2013-05 0 $0 227,590 $22,300,778 217,416 $14,957,606
2013-04 0 $0 30,533 $2,871,660 25,352 $1,717,388
2012-09 0 $0 35,000 $3,141,040 0 $0
2012-08 0 $0 2,536 $224,714 2,536 $76,992
2012-07 0 $0 123,341 $11,472,323 122,200 $7,274,560
2012-06 0 $0 4,365 $376,348 0 $0
2012-05 0 $0 2,663 $232,227 2,647 $137,227
2012-04 0 $0 4,000 $367,280 0 $0
2012-03 0 $0 93,061 $8,346,084 74,833 $4,885,154
2012-02 0 $0 60,000 $5,398,800 0 $0
2012-01 0 $0 20,000 $1,840,000 20,000 $1,171,400
2011-12 0 $0 20,000 $1,760,000 20,000 $957,800
2011-08 0 $0 817 $65,328 1,353 $64,971
2011-05 0 $0 23,388 $2,326,623 23,388 $1,732,536
2011-04 0 $0 169,138 $16,145,183 175,948 $10,282,218
2011-03 0 $0 5,371 $489,867 0 $0
2011-02 0 $0 34,869 $3,079,750 30,367 $1,823,234
2010-12 0 $0 185,366 $15,845,689 205,366 $10,203,924
2010-10 0 $0 36,762 $2,938,460 35,000 $2,049,950
2010-09 0 $0 1,896 $140,901 1,896 $64,938
2010-07 6,100 $453,345 924 $70,224 0 $0
2010-06 0 $0 617 $46,748 617 $39,747
2010-04 0 $0 99,341 $7,703,571 112,482 $4,842,623
2010-03 0 $0 34,035 $2,532,600 30,000 $1,170,000
2010-01 0 $0 50,337 $3,876,081 50,337 $2,191,168
2009-12 0 $0 10,000 $740,000 0 $0
2009-11 0 $0 4,116 $307,024 4,116 $64,954
2009-09 0 $0 6,720 $461,886 4,116 $64,954
2009-08 0 $0 854 $59,353 0 $0
2009-05 0 $0 1,407 $86,854 0 $0
2009-04 0 $0 3,500 $223,580 0 $0
2009-02 0 $0 6,066 $374,915 0 $0
2008-11 0 $0 276,237 $17,033,650 238,400 $10,096,692
2008-10 400 $24,384 0 $0 0 $0
2008-08 0 $0 414,872 $27,920,599 200,000 $7,800,000
2008-05 0 $0 18,072 $1,353,831 0 $0
2008-03 0 $0 504,375 $38,107,452 174,733 $7,290,696
2008-02 0 $0 157,563 $12,576,165 104,000 $4,056,000
2007-12 0 $0 2,386 $170,956 0 $0
2007-11 0 $0 363,000 $24,775,999 200,000 $7,240,200
2007-10 0 $0 35,000 $2,405,584 35,000 $1,143,100
2007-08 0 $0 374,889 $27,124,195 204,000 $6,768,399
2007-07 0 $0 43,700 $3,496,220 43,700 $1,991,979
2007-06 0 $0 1,748 $139,492 1,300 $56,571
2007-05 0 $0 17,837 $1,401,242 10,966 $296,623
2007-04 0 $0 146,973 $10,909,042 220,000 $6,710,000
2007-03 0 $0 928 $67,848 0 $0
2007-02 0 $0 105,000 $8,359,969 69,969 $2,931,748
2007-01 0 $0 8,345 $612,471 8,015 $268,165
2006-11 0 $0 140,617 $9,536,970 62,067 $1,568,768
2006-08 0 $0 17,241 $1,127,876 16,752 $776,940
2006-07 0 $0 10,000 $630,000 10,000 $478,900
2006-06 0 $0 8,417 $507,123 1,753 $58,623
2006-05 0 $0 169,534 $9,907,495 127,481 $4,418,656
2006-04 0 $0 918 $55,080 918 $39,959
2006-03 0 $0 19,170 $1,113,441 6,800 $290,174
2006-02 0 $0 316,555 $18,394,765 205,399 $6,517,310
2006-01 0 $0 399,463 $22,030,367 370,734 $15,344,166
2005-12 0 $0 1,991 $109,505 0 $0
2005-11 0 $0 60,000 $2,890,740 0 $0
2005-07 0 $0 18,000 $891,450 0 $0
2005-05 0 $0 43 $2,171 0 $0
2005-04 0 $0 115,030 $5,526,652 0 $0
2005-03 0 $0 52,606 $2,409,308 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Laboratory Corp Of America Holdings insiders (LH)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-30 Gilliland Dwight Gary (Director) Sale 971 153.52 149,067
2017-09-06 King David P (President & CEO) Sale 44,687 157.05 7,018,227
2017-09-06 King David P (President & CEO) Option Ex 44,687 90.74 4,054,898
2017-09-05 King David P (President & CEO) Sale 132,713 157.06 20,843,372
2017-09-05 King David P (President & CEO) Option Ex 132,713 90.74 12,042,377
2017-09-01 Gary M. Huff (CEO, LabCorp Diagnostics) Option Ex 153 .00 0
2017-08-25 Eberts F Samuel Iii (Chief Legal Officer, Secretary) Sale 31,500 155.22 4,889,461
2017-08-25 Eberts F Samuel Iii (Chief Legal Officer, Secretary) Option Ex 31,500 68.61 2,161,120
2017-08-11 Williams R Sanders (Director) Sale 3,100 156.85 486,241
2017-08-11 Williams R Sanders (Director) Option Ex 3,100 77.19 239,289
2017-08-01 Uthgenannt Lisa J (Chief Human Resources Officer) Sale 5,000 160.00 800,000
2017-08-01 Dodson Edward T (Principal Accounting Officer) Sale 2,871 160.13 459,730
2017-08-01 Eisenberg Glenn A (Chief Financial Officer, EVP) Sale 5,968 159.46 951,669
2017-06-16 Eisenberg Glenn A (Chief Financial Officer, EVP) Option Ex 4,050 .00 0
2017-05-22 Berberian Lance (SVP, Chief Information Officer) Sale 3,613 139.84 505,259
2017-05-09 Belingard Jean-luc (Director) Sale 992 142.19 141,052
2017-05-09 Belingard Jean-luc (Director) Option Ex 992 77.58 76,959
2017-03-11 Uthgenannt Lisa J (Chief Human Resources Officer) Option Ex 8,217 .00 0
2017-03-11 Dodson Edward T (Principal Accounting Officer) Option Ex 400 .00 0
2017-03-11 King David P (President & CEO) Option Ex 6,077 .00 0
2017-03-11 Eberts F Samuel Iii (Chief Legal Officer, Secretary) Option Ex 463 .00 0
2017-03-11 Eisenberg Glenn A (Chief Financial Officer, EVP) Option Ex 1,627 .00 0
2017-03-11 Berberian Lance (SVP, Chief Information Officer) Option Ex 400 .00 0
2017-03-09 Eisenberg Glenn A (Chief Financial Officer, EVP) Sale 2,300 142.47 327,671
2017-02-24 Anderson Kerrii B (Director) Option Ex 1,000 75.63 75,630
2017-02-24 Mittelstaedt Robert E Jr (Director) Sale 5,300 142.69 756,283
2017-02-24 Mittelstaedt Robert E Jr (Director) Option Ex 5,300 75.63 400,839
2017-02-23 Anderson Kerrii B (Director) Sale 1,992 140.00 278,880
2017-02-23 Anderson Kerrii B (Director) Option Ex 1,992 76.61 152,597
2017-02-11 Dodson Edward T (Principal Accounting Officer) Option Ex 550 .00 0
2017-02-11 Eberts F Samuel Iii (Chief Legal Officer, Secretary) Option Ex 634 .00 0
2017-02-09 Uthgenannt Lisa J (Chief Human Resources Officer) Option Ex 603 .00 0
2017-02-09 Dodson Edward T (Principal Accounting Officer) Option Ex 450 .00 0
2017-02-09 Gilliland Dwight Gary (Director) Option Ex 1,560 .00 0
2017-02-09 Ratliff John D (CEO, Covance Drug Development) Option Ex 6,100 .00 0
2017-02-09 Parham Richelle P (Director) Option Ex 1,560 .00 0
2017-02-09 Kong Garheng (Director) Option Ex 1,560 .00 0
2017-02-09 Schechter Adam H (Director) Option Ex 1,560 .00 0
2017-02-09 Williams R Sanders (Director) Option Ex 1,560 .00 0
2017-02-09 King David P (President & CEO) Option Ex 7,543 .00 0
2017-02-09 Neupert Peter M (Director) Option Ex 1,560 .00 0
2017-02-09 Eberts F Samuel Iii (Chief Legal Officer, Secretary) Option Ex 520 .00 0
2017-02-09 Anderson Kerrii B (Director) Option Ex 1,560 .00 0
2017-02-09 Eisenberg Glenn A (Chief Financial Officer, EVP) Option Ex 4,876 .00 0
2017-02-09 Mittelstaedt Robert E Jr (Director) Option Ex 1,560 .00 0
2017-02-09 Belingard Jean-luc (Director) Option Ex 1,560 .00 0
2017-02-09 Berberian Lance (SVP, Chief Information Officer) Option Ex 3,496 .00 0
2016-08-09 Uthgenannt Lisa J (Chief Human Resources Officer) Sale 1,177 140.00 164,780
2016-08-04 Eisenberg Glenn A (Chief Financial Officer, EVP) Sale 8,000 140.38 1,123,000
2016-08-04 Mittelstaedt Robert E Jr (Director) Sale 992 140.15 139,026
2016-08-04 Mittelstaedt Robert E Jr (Director) Option Ex 992 77.58 76,959
2016-06-16 Eisenberg Glenn A (Chief Financial Officer, EVP) Option Ex 8,100 .00 0
2016-06-13 King David P (President & CEO) Sale 196,400 128.42 25,221,491
2016-06-13 King David P (President & CEO) Option Ex 196,400 70.15 13,777,460
2016-04-29 Uthgenannt Lisa J (Chief Human Resources Officer) Sale 3,740 125.17 468,135
2016-04-27 Dodson Edward T (Principal Accounting Officer) Sale 9,392 126.42 1,187,336
2016-03-31 Boyle James T. Jr. (EVP,CEO of LabCorp Diagnostics) Sale 18,132 116.93 2,120,174
2016-03-31 Eberts F Samuel Iii (Chief Legal Officer, Secretary) Sale 4,219 116.85 492,990
2016-03-14 Boyle James T. Jr. (EVP,CEO of LabCorp Diagnostics) Sale 1,543 115.32 177,938
2016-03-14 Eberts F Samuel Iii (Chief Legal Officer, Secretary) Sale 309 115.32 35,633
2016-03-11 Uthgenannt Lisa J (Chief Human Resources Officer) Option Ex 8,216 .00 0
2016-03-11 Dodson Edward T (Principal Accounting Officer) Option Ex 400 .00 0
2016-03-11 Gilliland Dwight Gary (Director) Option Ex 1,237 .00 0
2016-03-11 Boyle James T. Jr. (EVP,CEO of LabCorp Diagnostics) Option Ex 2,956 .00 0
2016-03-11 Kong Garheng (Director) Option Ex 1,237 .00 0
2016-03-11 Schechter Adam H (Director) Option Ex 1,237 .00 0
2016-03-11 Williams R Sanders (Director) Option Ex 1,237 .00 0
2016-03-11 Keller Deborah L (CEO, Covance Drug Development) Option Ex 12,930 .00 0
2016-03-11 King David P (President & CEO) Option Ex 6,076 .00 0
2016-03-11 Neupert Peter M (Director) Option Ex 1,237 .00 0
2016-03-11 Eberts F Samuel Iii (Chief Legal Officer, Secretary) Option Ex 463 .00 0
2016-03-11 Anderson Kerrii B (Director) Option Ex 1,237 .00 0
2016-03-11 Eisenberg Glenn A (Chief Financial Officer, EVP) Option Ex 1,626 .00 0
2016-03-11 Mittelstaedt Robert E Jr (Director) Option Ex 1,237 .00 0
2016-03-11 Belingard Jean-luc (Director) Option Ex 1,237 .00 0
2016-03-11 Berberian Lance (SVP, Chief Information Officer) Option Ex 400 .00 0
2016-02-25 Belingard Jean-luc (Director) Sale 1,296 109.72 142,203
2016-02-25 Belingard Jean-luc (Director) Option Ex 1,296 59.37 76,943
2016-02-16 Boyle James T. Jr. (EVP,CEO of LabCorp Diagnostics) Sale 4,055 103.02 417,746
2016-02-16 Eberts F Samuel Iii (Chief Legal Officer, Secretary) Sale 370 103.02 38,117
2016-01-08 Eberts F Samuel Iii (Chief Legal Officer, Secretary) Sale 1,215 119.05 144,645
2015-12-08 Eberts F Samuel Iii (Chief Legal Officer, Secretary) Sale 1,010 123.31 124,543
2015-11-02 Williams R Sanders (Director) Sale 1,850 124.30 229,958
2015-11-02 Williams R Sanders (Director) Option Ex 1,850 64.42 119,177
2015-10-29 Anderson Kerrii B (Director) Option Ex 1,296 59.37 76,943
2015-08-03 King David P (President & CEO) Sale 50,000 128.06 6,402,900
2015-08-03 King David P (President & CEO) Option Ex 50,000 80.37 4,018,500
2015-07-31 Herring Joseph L (CEO of Covance Drug Division) Option Ex 19,990 .00 0
2015-07-01 King David P (President & CEO) Sale 50,000 121.72 6,086,200
2015-07-01 King David P (President & CEO) Option Ex 50,000 80.37 4,018,500
2015-06-16 Eisenberg Glenn A (Chief Financial Officer, EVP) Option Ex 4,050 .00 0
2015-06-01 King David P (President & CEO) Sale 50,000 118.23 5,911,500
2015-06-01 King David P (President & CEO) Option Ex 50,000 80.37 4,018,500
2015-05-19 Mittelstaedt Robert E Jr (Director) Sale 1,296 119.02 154,249
2015-05-19 Mittelstaedt Robert E Jr (Director) Option Ex 1,296 59.37 76,943
2015-05-11 Williams R Sanders (Director) Sale 965 118.06 113,929
2015-04-29 Belingard Jean-luc (Director) Sale 1,542 123.10 189,820
2015-04-29 Belingard Jean-luc (Director) Option Ex 1,542 49.93 76,992
2015-04-23 Boyle James T. Jr. (EVP,CEO of LabCorp Diagnostics) Sale 1,394 126.56 176,424
2015-04-01 Gilliland Dwight Gary (Director) Option Ex 172 .00 0
2015-03-31 Brecher Mark E (CMO, LabCorp Diagnostics) Sale 347 127.00 44,069
2015-03-30 Brecher Mark E (CMO, LabCorp Diagnostics) Sale 20,278 126.98 2,574,940
2015-03-30 Brecher Mark E (CMO, LabCorp Diagnostics) Option Ex 19,200 87.80 1,685,760
2015-03-03 Boyle James T. Jr. (EVP, Chief Operating Officer) Sale 1,237 123.70 153,021
2015-02-26 Williams R Sanders (Director) Sale 2,267 123.96 281,024
2015-02-25 Herring Joseph L (CEO of Covance Drug Division) Sale 36,876 121.79 4,491,201
2015-02-13 Boyle James T. Jr. (EVP, Chief Operating Officer) Sale 3,883 116.66 452,990
2015-02-12 Dodson Edward T (Principal Accounting Officer) Option Ex 547 .00 0
2015-02-12 Brecher Mark E (Chief Medical Officer) Option Ex 547 .00 0
2015-02-12 Boyle James T. Jr. (EVP, Chief Operating Officer) Sale 2,714 116.71 316,750
2015-02-12 Boyle James T. Jr. (EVP, Chief Operating Officer) Option Ex 6,170 .00 0
2015-02-12 King David P (President & CEO) Option Ex 8,270 .00 0
2015-02-12 Eberts F Samuel Iii (Chief Legal Officer, Secretary) Option Ex 547 .00 0
2015-02-12 Eisenberg Glenn A (Chief Financial Officer, EVP) Option Ex 1,540 .00 0
2015-02-11 Dodson Edward T (Principal Accounting Officer) Option Ex 550 .00 0
2015-02-11 Brecher Mark E (Chief Medical Officer) Option Ex 563 .00 0
2015-02-11 Boyle James T. Jr. (EVP, Chief Operating Officer) Option Ex 4,056 .00 0
2015-02-11 King David P (President & CEO) Option Ex 8,343 .00 0
2015-02-11 Eberts F Samuel Iii (Chief Legal Officer, Secretary) Option Ex 633 .00 0
2015-02-11 Eisenberg Glenn A (Chief Financial Officer, EVP) Option Ex 1,673 .00 0
2015-02-10 Gilliland Dwight Gary (Director) Option Ex 1,503 .00 0
2015-02-10 Kong Garheng (Director) Option Ex 1,503 .00 0
2015-02-10 Schechter Adam H (Director) Option Ex 1,503 .00 0
2015-02-10 Williams R Sanders (Director) Option Ex 1,503 .00 0
2015-02-10 Neupert Peter M (Director) Option Ex 1,503 .00 0
2015-02-10 Anderson Kerrii B (Director) Option Ex 1,503 .00 0
2015-02-10 Mittelstaedt Robert E Jr (Director) Option Ex 1,503 .00 0
2015-02-10 Belingard Jean-luc (Director) Option Ex 1,503 .00 0
2014-12-02 Kong Garheng (Director) Option Ex 624 .00 0
2014-09-22 King David P (President & CEO) Sale 65,234 105.11 6,856,876
2014-09-22 King David P (President & CEO) Option Ex 65,234 75.63 4,933,647
2014-09-05 Williams R Sanders (Director) Sale 2,000 107.95 215,910
2014-08-22 King David P (President & CEO) Sale 65,233 106.10 6,921,482
2014-08-22 King David P (President & CEO) Option Ex 65,233 75.63 4,933,571
2014-07-22 King David P (President & CEO) Sale 65,233 105.77 6,899,368
2014-07-22 King David P (President & CEO) Option Ex 65,233 75.63 4,933,571
2014-06-09 Boyle James T. Jr. (EVP, Chief Operating Officer) Sale 38,600 103.00 3,975,800
2014-06-09 Boyle James T. Jr. (EVP, Chief Operating Officer) Option Ex 38,600 84.86 3,275,596
2014-06-06 Hayes William B (Chief Financial Officer, EVP) Sale 47,367 104.25 4,937,772
2014-06-06 Hayes William B (Chief Financial Officer, EVP) Option Ex 47,367 87.80 4,158,822
2014-06-06 Eberts F Samuel Iii (Chief Legal Officer, Secretary) Sale 10,000 104.37 1,043,700
2014-06-06 Eberts F Samuel Iii (Chief Legal Officer, Secretary) Option Ex 10,000 60.04 600,400
2014-06-04 Brecher Mark E (Chief Medical Officer) Sale 2,600 102.31 266,006
2014-05-08 Schechter Adam H (Director) Option Ex 1,593 98.96 157,643
2014-05-08 Williams R Sanders (Director) Option Ex 1,593 98.96 157,643
2014-05-08 Rubenstein Arthur H (Director) Option Ex 1,593 98.96 157,643
2014-05-08 Neupert Peter M (Director) Option Ex 1,593 98.96 157,643
2014-05-08 Anderson Kerrii B (Director) Option Ex 1,593 98.96 157,643
2014-05-08 Lane Wendy E (Director) Option Ex 1,593 98.96 157,643
2014-05-08 Mittelstaedt Robert E Jr (Director) Option Ex 1,593 98.96 157,643
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of LH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Laboratory Corp Of America Holdings (symbol LH, CIK number 920148) see the Securities and Exchange Commission (SEC) website.